A study labeled “National research priority” is coordinated by the hospital practitioner of vascular medicine at the Nancy CHRU and researcher, the Pr Stéphane Zuily, since April. Twenty-four centers are involved in twenty French hospitals. “Covi-Dose” aims to identify the best dose of anticoagulant in order to prevent the risk of thrombosis in patients hospitalized after infection with Covid-19. “We know that the virus kills and that it increases the risk of thrombosis,” says Stéphane Zuily. One in twenty people in conventional hospitalization and one in five patients in intensive care may be exposed to …
–
Related posts:
The Party Group of the Beijing Municipal Intellectual Property Bureau studied and discussed the spir...
Brawl Erupts in Yogyakarta, Prompting Police Response and Road Closures
They press for the Streets without Violence plan to be extended to Ch. Viejo – La Discusión
OL will go to Reims on March 12 at 9 p.m.
